Heyholder

GC Medical Science Corporation Disclosures

142280 · KOSDAQ

Disclosures

1 total · 20 per page

Newest first

Preliminary Earnings

GC Medical Science's Q3 2026 consolidated revenue was KRW 27.0 billion, up 2.3% year over year, and operating profit was KRW 1.1 billion, up 20.4%.

Catch the next disclosure fast

Get app alerts for new disclosures from GC Medical Science Corporation.